Management of thromboembolic disease in cancer patients.
Levine
M N
MN
McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada. mlevine@fhs.csu.mcmaster.ca
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D013923:Thromboembolism / Q000209:etiology / Q000628:therapy*; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000209:etiology / Q000628:therapy
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight